Comprehensive characterization of TGFB1 across hematological malignancies
Abstract TGFB1, which encodes TGF-β1, a potent cytokine regulating varies cellular processes including immune responses. TGF-β1 plays context-dependent roles in cancers and is increasingly recognized as a therapeutic target to enhance immunotherapy responses. We comprehensively evaluated expression...
Main Authors: | Cui-zhu Wang, Zi-qi Zhang, Yan Zhang, Liang-feng Zheng, Yang Liu, Ai-ting Yan, Yuan-cui Zhang, Qing-hua Chang, Suo Sha, Zi-jun Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-46552-8 |
Similar Items
-
TCF12 Activates TGFB2 Expression to Promote the Malignant Progression of Melanoma
by: Youjia Tian, et al.
Published: (2023-09-01) -
Clinical characteristics and identification of a novel TGFB1 variant in three unrelated Chinese families with Camurati‐Engelmann disease
by: Xiao‐Hui Tao, et al.
Published: (2022-05-01) -
Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety—A Systematic Review with Meta-Analysis
by: Wen-Liang Yu, et al.
Published: (2019-01-01) -
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
by: Yu Zhu, et al.
Published: (2023-02-01) -
No association between TGFB1 polymorphisms and late radiotherapy toxicity: a meta-analysis.
by: Mei-Ling Zhu, et al.
Published: (2013-01-01)